Copyright
©The Author(s) 2022.
World J Gastroenterol. Sep 28, 2022; 28(36): 5280-5299
Published online Sep 28, 2022. doi: 10.3748/wjg.v28.i36.5280
Published online Sep 28, 2022. doi: 10.3748/wjg.v28.i36.5280
Platform | Composition | Origin | Benefits | Limitations |
Lipid-based | ||||
Liposomes | Lipids | Synthetic | Non-immunogenic, non-toxic, modifiable | High clearance by liver/spleen RES |
Exosomes | Lipids | Biological | Endogenous cargo (proteins, nucleic acids, etc.), but can add additional cargo | Non-standardized isolation methods, potentially immunogenic |
Micelles | Lipids | Biological | Non-immunogenic, non-toxic, modifiable | High clearance by liver/spleen RES |
Non-lipid-based | ||||
Polymeric nanoparticles | Polymers | Synthetic | Modifiable, capable of controlled drug release | High clearance by liver/spleen RES, potentially immunogenic |
Metallic nanoparticles | Gold, silver, aluminum, zinc, iron, gadolinium, copper, rubidium, palladium, titanium | Synthetic | Modifiable, magnetic (iron), anti-microbial (copper, silver, titanium) | Non-biodegradable and potentially cytotoxic, immunogenic, or allergenic |
Ceramic nanoparticles | Carbon, silicon with metallic or non-metallic core | Synthetic | Modifiable, resistant to pH change | Potentially cytotoxic or immunogenic, non-biodegradable or lowly biodegradable |
Bacterial and viral | ||||
Bacteria | Bacterial cells | Biological | Self-propulsion, chemotaxis, on-site drug production, transfection | Immunogenicity, infection risk |
Viral vectors | AAVs, HSVs | Biological | Active liver tropism | Immunogenicity, toxicity, neutralizing antibodies |
- Citation: Warner JB, Guenthner SC, Hardesty JE, McClain CJ, Warner DR, Kirpich IA. Liver-specific drug delivery platforms: Applications for the treatment of alcohol-associated liver disease. World J Gastroenterol 2022; 28(36): 5280-5299
- URL: https://www.wjgnet.com/1007-9327/full/v28/i36/5280.htm
- DOI: https://dx.doi.org/10.3748/wjg.v28.i36.5280